Role of PRL-3, Snail, Cytokeratin and Vimentin expression in epithelial mesenchymal transition in breast carcinoma

Breast Disease

Volumn 35, Issue 2, 2015, Pages 113-127

  Patel, Nupur A ^a   Patel, Prabhudas S ^a   Vora, Hemangini H ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

Author keywords

breast carcinoma; EMT; Vimentin

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKERATIN; DOXORUBICIN; FLUOROURACIL; MESSENGER RNA; METHOTREXATE; ONCOPROTEIN; PRL3 PROTEIN; TAMOXIFEN; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; VIMENTIN; KERATIN; PROTEIN TYROSINE PHOSPHATASE; PTP4A3 PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE FREE SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN PROCESSING; REFERENCE VALUE; RETROSPECTIVE STUDY; BREAST TUMOR; CANCER GRADING; CARCINOMA; COLLOID CARCINOMA; GENETICS; KAPLAN MEIER METHOD; LUNG CARCINOMA; MEDULLARY CARCINOMA; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA, MUCINOUS; ADULT; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; DISEASE-FREE SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KERATINS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROTEIN TYROSINE PHOSPHATASES; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; VIMENTIN;

EID: 84931097138     PISSN: 08886008     EISSN: 15581551     Source Type: Journal    
DOI: 10.3233/BD-140395     Document Type: Article

References (32)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v 1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11.
2. Wang Haihe, Yiling Quah Samantha, Dong Jing Ming, et al. PRL-3 Down-regulates PTEN Expression and Signals through PI3K to Promote Epithelial-Mesenchymal Transition. Cancer Res 2007; 67: 2922-6.
3. Thiery, JP. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002; 2: 442-54.
4. Nieto MA. The Snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol 2002; 3: 155-66.
5. Miskad U, Semba S, Kato H, Yokozaki H. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Pathobiology 2004; 71: 176-84.
6. Kato H, Semba S, Miskad U, Seo Y, Kasuga M, Yokozaki H. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin Cancer Res 2004; 10: 7318-28.
7. Yamashita S, Masuda Y, Matsumoto K, Okumura Y, et al. Down-regulation of the human PRL-3 gene is associated with the metastasis of primary non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2007; 13: 236-9.
8. Polato F, Codegoni A, Fruscio R, et al. PRL-3 phosphatase is implicated in ovarian cancer growth. Clin Cancer Res 2005; 11: 6835-9.
9. Xing Xiaofang, Lian Shenyi, Hu Ying, et al. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma. Journal of Translational Medicine 2013; 11: 309.
10. Zhao WB, Li Y, Liu X, Zhang LY, Wang X. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma. Int J Mol Med 2008; 22: 187-92.
11. Saha S, Bardelli A, Buckhaults P. A phosphatase associated with metastasis of colorectal cancer. Science 2001; 294: 1343-6.
12. Bardelli A, Saha S, Sager J, et al. PRL-3 expression in metastatic cancers. Clin Cancer Res 2003; 9: 5607-15.
13. Rouleau C, Roy A, St Martin T, Dufault M, Boutin P, et al. Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function. Mol Cancer Ther 2006; 5: 219-29.
14. Radke I, Gotte M, Kersting C, Mattsson B, Kiesel L, Wulfing P. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2 and PRL-3 in breast cancer Br J Cancer 2006; 95: 347-54
15. Wang L, Peng L, Dong B, Kong L, Meng L, Yan L, Xie Y, Shou C. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome Annals of Oncology 2006; 17: 1517-1522.
16. Hanan Mohamed, Nasser Mohammed. Expression of e-cadherin, n-cadherin and Snail and their correlation with clinicopathological variants: An immunohistochemical study of 132 invasive ductal breast carcinomas in Egypt Clinics 2011; 66: 1765-71.
17. Logullo AF, Nonogaki S, Pasini FS, et al. Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: Association with progression. Oncology Reports 2010; 23: 313-20.
18. Muenst S, Däster S, Obermann EC, et al. Nuclear expression of Snail is an independent negative prognostic factor in human breast cancer. Disease Markers 2013; 35(5): 337-44.
19. Toyama Tatsuya, Zhang Zhenhuan, Iwase Hirotaka, et al. Low expression of the Snail Gene is a good prognostic factor in node-negative invasive ductal carcinomas. Jpn J Clin Oncol 2006; 36(6): 357-363.
20. Cai Jinquan. Roles of transcriptional factor Snail and adhesion factor E-cadherin in clear cell renal cell carcinoma. Experimental and Therapeutic Medicine 2013; 6: 1489-93.
21. Yuen HF, Chan YK, Grills C. McCrudden, et al. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail induced epithelial-mesenchymal transition. Journal of Pathology 2011; 224(01): 78-89.
22. Fuchs IB, Lichtenegger W, Buehler H. The prognostic significance of epithelial mesenchymal transition in breast cancer. Anticancer Res 2002; 22: 3415-20.
23. Takei H, Iino Y, Horiguchi J. Immunohistochemical analysis of cytokeratin 8 as a prognostic factor in invasivebreast carcinoma. Anticancer Res 1995; 19: 1101-5.
24. Willipinski-Stapelfeldt B, Riethdorf S, Assmann V. Changes in cytoskeletal protein composition indicative of an epithelialmesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 2005; 11: 8006-14.
25. Alshareeda Alaa T, Soria Daniele, Garibaldi Jonathan M, Rakha Emad, et al. Characteristics of basal cytokeratin expression in breast cancer Breast Cancer Res Treat 2013. Online published April 2013.
26. Abd El Rehim DM, Pinder SE, Paish CE, Bell J. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 2004; 203: 661-71.
27. Maureen Hong-Sing Chen, George Wai-Cheong Yip, Gary Man-Kit Tse, et al. Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters. Modern Pathology 2008; 21: 1183-1191.
28. Vora HH, Patel NA, Rajvik KN, et al. Cytokeratin and vimentin expression in breast cancer. Int Journal of biological markers 2009; 24(1): 36-48.
29. Planas-Silva, Waltz PK. Estrogen promotes reversible epithelial to mesenchymal-like transition and collective motility in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 2007; 104: 11-21.
30. Thomas PA, Kirschmann DA, Cerhan JR. Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin Cancer Res 1999; 5: 2698-2703.
31. Sheshadri R, Raymond WA, Leong AS, et al. Vimentin expression is not associated with poor prognosis in breast cancer. Int J Cancer 1996; 67: 353-6.
32. Solanas G, Porta-de-la-Riva M, Agusti C, et al. E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression. J Cell Sci 2008; 121: 2224-34.